Boston hearing-tech startup Legato said on October 1, 2026 that its flagship Legato Frames are NOW available to U.S. buyers, putting AI-powered HEARING assistance into EVERYDAY prescription eyewear. The company prices the frames from $999 and sells them ONLINE through legatohearing.com, with select eye-care providers expected to FOLLOW. Coverage notes that vision insurance may APPLY when frames are purchased through a clinic.
According to Legato’s GlobeNewswire announcement and contemporaneous TechCrunch reporting, the product targets adults with up to moderate hearing LOSS. Frames ship in THREE styles, including Aria, an acetate-and-metal browline DESIGN. Hearing hardware sits in the ARMS, and each pair SUPPORTS prescription lenses with Pentax optics.
SpeechSense Processing Runs ON-DEVICE
Legato’s patented SpeechSense system is designed to SEPARATE speech from BACKGROUND noise and AMPLIFY voices in REAL TIME. The company says ALL processing stays on the glasses, with NO cameras and NO recording. An open-ear dual-speaker system directs sound toward the wearer while CUTTING escaping audio by about 99% a few inches away, so nearby people are not meant to hear the stream.
Weight is listed as little as 34 grams with lenses, with 10–12 hours of battery life for ALL-DAY wear. Bluetooth streaming covers music and CALLS on iPhone and Android. Legato also bundles FREE lifetime SUPPORT from its U.S.-based audiologists and product specialists. In May 2026 testing, HearAdvisor scored the frames 4.6 out of 5, ranking them among the TOP 10 devices the lab had MEASURED, spanning over-the-counter and higher-priced prescription aids.
Founders BRIDGE Wearables and Hearing Care
Co-founders Mehul Trivedi and Steve Romine built careers at Bose — Trivedi on Bose Frames, Romine on hearing products — before Trivedi led smart-eyewear work at EssilorLuxottica tied to Meta Ray-Ban glasses and Romine later served as chief operating officer at Audicus. They founded Legato in 2024. In August 2026 the company EMERGED from stealth with $12 million from Neotribe Ventures, Listen, and Village Global, previewing Frames for a later fall launch that has NOW ARRIVED.
Legato frames the U.S. opportunity around STIGMA and ADOPTION: it cites roughly 50 million American adults with recognized hearing loss and says about 80% of people who could BENEFIT still do not use hearing aids. The company also POINTS to a 2024 Lancet Commission meta-analysis linking hearing-device use to LOWER risks of cognitive decline and dementia among people with hearing loss — CONTEXT for why a glasses-shaped form FACTOR matters beyond fashion.
Regulatory positioning is CLEAR in the press materials: Legato Frames are FDA-regulated over-the-counter hearing aids for mild-to-moderate loss, designed under federal rules for SAFETY, performance, labeling, and consumer protections. For the broader AI-glasses MARKET — Meta Ray-Ban lines, Snap SPECS, Android XR audio frames — Legato is a PARALLEL bet: less camera HUD, more clinical HEARING UTILITY in a form people already WEAR.
Buyers can order NOW at legatohearing.com. Primary sources for this report are Legato’s October 1, 2026 GlobeNewswire RELEASE and TechCrunch’s same-day launch COVERAGE; earlier August reporting documented the $12 million RAISE and product PREVIEW.